Professionally Cannabis & Psychedelics Professionally Cannabis & Psychedelics

Today’s episode will be slightly different to the norm… Having received a few notes from newer listeners keen to understand more about individual cannabinoids, I thought it would be cool this week to play out a session that ran last year at the GCI Summit with none other than Dr. Ethan Russo.  

As one of the modern-day OGs of cannabis research and science, it is always a pleasure to pick the brain of Ethan, who is an unequivocal authority on the plant and its constituent parts. 

As a heads up, the session was initially recorded on Zoom, so the audio quality will be slightly different to the typical pods; however, I hope that hearing the wonderful insights of Dr. Russo will be enough of an audio feast for you!

Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content on the GCI Content Hub: https://contenthub.gcintelligence.com/ 

For this week’s episode, Tim Schlidt, Co-Founder and Partner at psychedelics VC firm, Palo Santo joined the pod in conversation.


The psychedelics industry has experienced growth at breakneck speed over the past two years, with swathes of ground-breaking research and cutting-edge companies looking to revolutionise mental health treatment as we know it. With over 20 companies across their portfolio of Psychedelic Pioneers, there’s no doubt that Tim has much to share on the latest innovations in the space, and the type of companies that are driving these forwards.


Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content on the GCI Content Hub: https://contenthub.gcintelligence.com/

For this week’s episode, we talk cannabis in Germany with Niklas Kouparanis, the Co-Founder & CEO of Bloomwell Group. 

With the biggest medical cannabis market in Europe and imminent plans to pass new laws permitting recreational use of the plant, Nik joins us to discuss the practicalities, time lines and critical success factors for Germany, as adult-use cannabis in the country has moved from an ‘if’ to a ‘when’. 

Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content on the GCI Content Hub: https://contenthub.gcintelligence.com/ 

Tune into today’s podcast to hear from Ben Lightburn, the Co-Founder & CEO of Filament Health. 

Listed on the NEO Exchange, Filament Health have many irons in the psychedelic fire, spearheading clinical trials (alongside the University of California, San Francisco), registering a whole host of IP and making strides forward within drug discovery. As a company that favours naturally derived psychedelics, rather than their synthetic counterparts, this is a must listen for anyone with a keen eye on psychedelic medicine!

Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content on the GCI Content Hub: https://contenthub.gcintelligence.com/ 

Earlier this year, I was joined by one of the most recognisable names for folks who operate on the business side of the cannabis industry - Terry Booth, the CEO of Audacious and Former CEO and Founder of Aurora Cannabis.

Having developed one of the largest cannabis companies worldwide, followed by leading further investments and ventures in the space, Terry is as candid and energetic as ever over our conversation!

Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content at: https://contenthub.gcintelligence.com/

The pod returns (following a short holiday and a longer illness!) with a conversation I had earlier this year with Zoe Helene, the Founder and Chief Visionary Officer of Cosmic Sister.
Zoe takes us on a psychedelic journey that kicked off in the 90s and delves into a range of topics, including Psychedelic Feminism. 

Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content on the GCI Content Hub: https://contenthub.gcintelligence.com/